Page last updated: 2024-10-17

malic acid and Graft vs Host Disease

malic acid has been researched along with Graft vs Host Disease in 1 studies

malic acid : A 2-hydroxydicarboxylic acid that is succinic acid in which one of the hydrogens attached to a carbon is replaced by a hydroxy group.
2-hydroxydicarboxylic acid : Any dicarboxylic acid carrying a hydroxy group on the carbon atom at position alpha to the carboxy group.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the clinical effectiveness of a topical sialogogue spray (malic acid, 1%) in the treatment of xerostomia in patients with chronic Graft versus Host Disease (cGVHD)."9.30Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease. ( Amadori, F; Bardellini, E; Conti, G; Majorana, A; Veneri, F, 2019)
"To evaluate the clinical effectiveness of a topical sialogogue spray (malic acid, 1%) in the treatment of xerostomia in patients with chronic Graft versus Host Disease (cGVHD)."5.30Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease. ( Amadori, F; Bardellini, E; Conti, G; Majorana, A; Veneri, F, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardellini, E1
Amadori, F1
Conti, G1
Veneri, F1
Majorana, A1

Trials

1 trial available for malic acid and Graft vs Host Disease

ArticleYear
Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease.
    Medicina oral, patologia oral y cirugia bucal, 2019, Mar-01, Volume: 24, Issue:2

    Topics: Adult; Double-Blind Method; Female; Graft vs Host Disease; Humans; Malates; Male; Middle Aged; Oral

2019